Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 3, 2026 · Material agreement · Other material event · Item 3.02 · +2 more
Liminatus Pharma, Inc.
11
Material agreement
Jun 3, 2026
| Item 1.01 | Entered a material definitive agreement |
| Item 3.02 | Item 3.02 |
| Item 3.03 | Item 3.03 |
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
Liminatus Pharma, Inc. filed this to report entering into or terminating a material contract that could affect operations, partnerships, or future hiring.
1 Liminatus Pharma Enters Into Warrant Exercise Transaction for $1. 9 Million in Gross Proceeds FULLERTON, CA, June 3, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc.
This filing reports Item 1.01 (entered a material definitive agreement); Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Liminatus Pharma, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
